A Phase I, Randomized, Open, Multi-center, Cross Over Study to Evaluate the Therapeutic Equivalence of Repeated Dose of HCP0910 250/50 mcg to SeretideTM 250 DiskusTM in Asthmatic Patients.
Phase of Trial: Phase I
Latest Information Update: 22 Aug 2013
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000396).
- 26 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.